DNAJC13 genetic variants in parkinsonism

Movement Disorders

Volumn 30, Issue 2, 2015, Pages 273-278

  Gustavsson, Emil K ^a,b,c   Trinh, Joanne ^a   Guella, Ilaria ^a   Vilariño Güell, Carles ^a   Appel Cresswell, Silke ^d   Stoessl, A Jon ^d   Tsui, Joseph K ^d   Mckeown, Martin ^d   Rajput, Alex ^e   Rajput, Ali H ^e   Aasly, Jan O ^b,c   Farrer, Matthew J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e SASKATOON HEALTH REGION   (Canada)

Author keywords

DNAJC13; Genetics; Mutations; NGS; Parkinsonism

Indexed keywords

LEVODOPA; PROTEIN DNAJ; PROTEIN DNAJC13; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTOPSY; CASE CONTROL STUDY; COGNITION; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DRUG RESPONSE; FEMALE; GAIT; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SEGREGATION ANALYSIS; SHY DRAGER SYNDROME; SYMPTOMATOLOGY; VERY ELDERLY;

EID: 84964297981     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26064     Document Type: Article

References (22)

1. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 2003;991:1-14.
2. Marder K, Levy G, Louis ED, et al. Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol 2003;54:507-513.
3. Sveinbjornsdottir S, Hicks AA, Jonsson T, et al. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 2000;343:1765-1770.
4. McDonnell SK, Schaid DJ, Elbaz A, et al. Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study. Ann Neurol 2006;59:788-795.
5. Vilarino-Guell C, Rajput A, Milnerwood AJ, et al. DNAJC13 mutations in Parkinson disease. Hum Mol Genet 2014;23:1794-1801.
6. Popoff V, Mardones GA, Bai SK, et al. Analysis of articulation between clathrin and retromer in retrograde sorting on early endosomes. Traffic 2009;10:1868-1880.
7. Chang HC, Hull M, Mellman I. The J-domain protein Rme-8 interacts with Hsc70 to control clathrin-dependent endocytosis in Drosophila. J Cell Biol 2004;164:1055-1064.
8. Zhang Y, Grant B, Hirsh D. RME-8, a conserved J-domain protein, is required for endocytosis in Caenorhabditis elegans. Mol Biol Cell 2001;12:2011-2021.
9. Edvardson S, Cinnamon Y, Ta-Shma A, et al. A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism. PLoS One 2012;7:e36458.
10. Cadieux-Dion M, Andermann E, Lachance-Touchette P, et al. Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease. Clin Genet 2013;83:571-575.
11. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism: a prospective study. Can J Neurol Sci 1991;18:275-278.
12. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010;38:e164.
13. Thusberg J, Olatubosun A, Vihinen M. Performance of mutation pathogenicity prediction methods on missense variants. Hum Mutat 2011;32:358-368.
14. Al-Chalabi A, Durr A, Wood NW, et al. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 2009;4:e7114.
15. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705.
16. Kara E, Ling H, Pittman AM, et al. The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobiol Aging 2012;33:e2231;e2237-2231;e2214.
17. Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009;65:610-614.
18. Foo JN, Liany H, Tan LC, et al. DNAJ mutations are rare in Chinese Parkinson's disease patients and controls. Neurobiol Aging 2014;35:935 e931-932.
19. Freeman CL, Hesketh G, Seaman MN. RME-8 coordinates the activity of the WASH complex with the function of the retromer SNX dimer to control endosomal tubulation. J Cell Sci 2014;127:2053-2070.
20. Vilarino-Guell C, Wider C, Ross OA, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet 2011;89:162-167.
21. Zimprich A, Benet-Pages A, Struhal W, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 2011;89:168-175.
22. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.